Comparing the SPRINT and the HOPE-3 Blood Pressure Trial
JAMA Cardiol
.
2016 Nov 1;1(8):855-856.
doi: 10.1001/jamacardio.2016.2051.
Authors
Paul K Whelton
1
,
David M Reboussin
2
,
Lawrence J Fine
3
Affiliations
1
Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana.
2
Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina.
3
Clinical Applications and Prevention Branch, Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, Maryland.
PMID:
27604076
DOI:
10.1001/jamacardio.2016.2051
No abstract available
MeSH terms
Antihypertensive Agents / therapeutic use*
Blood Pressure
Blood Pressure Determination
Clinical Trials as Topic
Humans
Hypertension / drug therapy*
Substances
Antihypertensive Agents